Tag Archives: monoclonal antibodies

Global Biosimilars Market to Reach $2.4 Billion in 2013

By Adeline Siew, Editor, Pharmaceutical Technology Europe. The global market for biosimilar drugs has been forecasted to be worth $2.445 billion this year, according to a new report by British market research specialist Visiongain. The growth represents a 20% increase from last year and accounts for approximately 2% of the overall biologics market. Moreover, the […]
Posted in Biotech, Global, Guest Blog, R&D | Also tagged , , | Leave a comment

Tufts R&D Outlook for 2011: Pain Mixed with Promise

The Tufts Center for Drug Development issues its annual assessment of the state of R&D in Big Pharma, noting that industry faces a cumulative tide of challenges marked by a dramatic reversal in societal attitudes toward risk. Productivity gaps in the pipeline aside, perhaps the biggest problem is political — convincing stakeholders to strive for […]
Posted in FDA, Gene therapy, R&D, Regulatory | Also tagged , , , , , | 1 Comment
  • Categories

  • Meta